Biotech Boom Expected to Continue
South Korea Emerges as Key Biotech Player, Focusing on Bioconvergence-Bioclusters
By Cornelia Zou
Wednesday, December 4, 2013
HONG KONG – Recent investments by global life sciences companies in Seoul underscores the newfound emphasis that South Korea is putting on the development of biotechnology as a key emerging industry.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.